High-Intensity Statins Before Percutaneous Coronary Intervention in Acute Coronary Syndrome-Should It Be Added to Treatment Algorithm?

Am J Cardiol. 2023 Jun 1:196:104-105. doi: 10.1016/j.amjcard.2023.03.019. Epub 2023 Apr 12.

Author

Donald E Cutlip¹

Affiliation

¹ Cardiology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. Electronic address: dcutlip@bidmc.harvard.edu.

PMID: 37059611
DOI: 10.1016/j.amjcard.2023.03.019

No abstract available

Publication types

Comment

MeSH terms

Acute Coronary Syndrome* / drug therapy
Coronary Artery Disease* / therapy
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Percutaneous Coronary Intervention*
Treatment Outcome

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors